5 results  1 of 1 

1 Long-term Outcomes of Clopidogrel Monotherapy versus Prolonged Dual Antiplatelet Therapy beyond 12 Months after Percutaneous Coronary Intervention in High-risk Patients
Dong-Yeon Kim, Sung Woo Cho, Kyu Tae Park, Jong-Hwa Ahn, Taek Kyu Park, Yong Ho Jang, Ki Hong Choi, Joo Myung Lee, Jeong Hoon Yang, Young Bin Song, Jin-Ho Choi, Seung-Hyuk Choi, Hyeon-Cheol Gwon, Sang Hoon Lee, Joo-Yong Hahn
J Korean Med Sci.2021;36(16):e106.  Published online 2021 April 5     DOI: http://dx.doi.org/10.3346/jkms.2021.36.e106
      
2 The Evolving Concept of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: Focus on Unique Feature of East Asian and “Asian Paradox”
Jeehoon Kang, Hyo-Soo Kim
Korean Circ J.2018;48(7):537-551.   Published online 2018 June 20     DOI: http://dx.doi.org/10.4070/kcj.2018.0166
      
3 Low-Molecular-Weight Heparin or Dual Antiplatelet Therapy Is More Effective Than Aspirin Alone in Preventing Early Neurological Deterioration and Improving the 6-Month Outcome in Ischemic Stroke Patients
Xingyang Yi, Wanzhang Chi, Chun Wang, Biao Zhang, Jing Lin
J Clin Neurol.2015;11(1):57-65.   Published online 2015 January 2     DOI: http://dx.doi.org/10.3988/jcn.2015.11.1.57
      
4 Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons
Keun-Sik Hong
J Clin Neurol.2014;10(3):189-196.   Published online 2014 July 3     DOI: http://dx.doi.org/10.3988/jcn.2014.10.3.189
      
5 Biliary-Pancreatic Endoscopic and Surgical Procedures in Patients under Dual Antiplatelet Therapy: A Single-Center Study
Ahmed Abdel Samie, Michael Stumpf, Rui Sun, Lorenz Theilmann
Clin Endosc.2013;46(4):395-398.   Published online 2013 July 31     DOI: http://dx.doi.org/10.5946/ce.2013.46.4.395
      

 1 of 1